Additional Information

Description

Tadalafil + Sildenafil Troches 22 mg/110 mg is a compounded medication used in the management of erectile dysfunction (ED). It combines two phosphodiesterase type 5 (PDE5) inhibitors—tadalafil and sildenafil—to enhance blood flow to the penile tissue, promoting improved erectile function. This dual-action formulation may be prescribed when monotherapy is insufficient or for tailored patient needs.

The troche is administered by placing it in the mouth and allowing it to dissolve, typically 30 to 60 minutes before sexual activity. Optimal absorption requires avoiding food and drink for at least two hours before and after administration. This sublingual route facilitates rapid onset of action and may enhance effectiveness in select patients.

Adverse effects may include headache, flushing, nasal congestion, and dizziness. A significant risk is hypotension, particularly when combined with nitrates, which is strictly contraindicated. Prolonged erections (priapism) require immediate medical attention to prevent long-term damage. Patients should be screened for cardiovascular risk before initiating treatment.